AcademicCME Podcast

Novel B-Cell Depleting Targeted Therapies to Improve Outcomes in Patients With Sjögren's Disease

Play Episode Listen Later Jun 9, 2026 21:09

This activity was supported by an educational grant from Novartis. Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://academiccme.com/courses/CCRSjDPod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through June 7, 2027

patients disease credit therapies novartis gren targeted therapy improve outcomes depleting

Improving Management of Difficult-to-Control Hypertension in Primary Care

Play Episode Listen Later Jun 1, 2026 40:47

This activity was supported by an educational grant from AstraZeneca Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Link⁠⁠⁠⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 15, 2027.

management improving difficult credit primary care hypertension

Migliorare la gestione dell'ipertensione difficilmente controllabile nell'assistenza primaria

Play Episode Listen Later Jun 1, 2026 48:12

Questa attività è stata sostenuta da un contributo formativo di AstraZeneca. Si prega di visitare il Link e completare la valutazione per ricevere i crediti CE/CME. I crediti sono disponibili fino al 15 marzo 2027.

astrazeneca questa primaria gestione migliorare difficilmente

Verbesserung des Managements schwer einstellbarer Hypertonie in der Primärversorgung

Play Episode Listen Later Jun 1, 2026 30:29

Diese Veranstaltung wurde durch ein Bildungsstipendium von AstraZeneca unterstützt. Bitte rufen Sie den Link auf und füllen Sie die Evaluierung aus, um Ihre CE/CME-Punkte zu erhalten. Die Punkte sind bis zum 15. März 2027 verfügbar.

management bitte astrazeneca prim verbesserung schwer evaluierung hypertonie diese veranstaltung

Melhoria do manejo da hipertensão de difícil controle na Atenção Primária

Play Episode Listen Later Jun 1, 2026 52:42

Esta atividade foi apoiada por um subsídio educacional da AstraZeneca. Por favor, acesse o Link e preencha a avaliação para receber seus créditos de Educação Continuada (CE/CME). Os créditos estarão disponíveis até 15 de março de 2027.

os educa astrazeneca controle prim manejo aten o melhoria hipertens

Beyond Factor Xa: FXI/XIa Inhibition and the Next Era of Stroke Prevention in Atrial Fibrillation

Play Episode Listen Later May 20, 2026 80:06

This activity was supported by an educational grant from the Bristol Myers Squibb and Johnson & Johnson Alliance. Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Link⁠⁠⁠⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through May 6, 2027.

credit factor next era bristol myers squibb atrial fibrillation inhibition stroke prevention

プライマリ・ケアにおける難治性高血圧管理の改善

Play Episode Listen Later May 5, 2026 36:32

本活動は、アストラゼネカ社からの教育助成により支援されました。CE/CME単位を取得するには、ACADEMICCME ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠にアクセスし、評価を完了してください。単位の取得は、2027年3月15日まで可能です。Hon katsudō wa, asutorazeneka-sha kara no kyōiku josei ni yori shien sa remashita. CE/ CME tan'i o shutoku suru ni wa, ACADEMICCME ni akusesu shi, hyōka o kanryō shite kudasai. Tan'i no shutoku wa, 2027-nen 3 tsuki 15-nichi made kanōdesu.

tan

Mejora del manejo de la hipertensión de difícil control en Atención primaria

Play Episode Listen Later May 5, 2026 43:12

Esta actividad contó con el apoyo de una subvención educativa de AstraZeneca. Por favor, acceda al enlace y complete la evaluación para recibir su crédito de educación continua (CE/CME). Los créditos estarán disponibles hasta el 15 de marzo de 2027.

astrazeneca atenci n mejora manejo primaria hipertensi

Updating the Efficacy and Safety Experience of IL-17 Inhibitors

Play Episode Listen Later Jan 22, 2026 40:00

This activity was supported by an educational grant from UCB Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://academiccme.com/courses/il17pod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 14, 2026.

safety credit efficacy inhibitors

Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies

Play Episode Listen Later Dec 11, 2025 54:38

This activity was supported by an educational grant from Amgen. Please go to ⁠academiccme.com/lipidpod25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 25, 2026.

data credit emerging approved lowering clinical trials therapies amgen lipids

Update on Long-Acting Nebulized Bronchodilators for Guidance-Based Maintenance for Patients with COPD

Play Episode Listen Later Dec 11, 2025 32:56

This activity was supported by an educational grant from Viatris Specialty LLC. Please go to ⁠⁠academiccme.com/epccopdpod2⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 29, 2026.

patients acting credit guidance maintenance copd nebulized

Therapeutic Update on COPD with Type 2 Inflammation

Play Episode Listen Later Nov 25, 2025 26:21

This activity was supported by an educational grant from GSK. Please go to academiccme.com/epccopd1pod and complete the evaluation to receive your CE/CME Credit. Credit is available through September 29, 2026.

credit inflammation therapeutic copd gsk type 2

Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making

Play Episode Listen Later Nov 24, 2025 63:18

This activity was supported by an educational grant from argenx. Credit is available through May 4, 2026.

strategy patients treatments credit personalized blockers shared decision making myasthenia gravis treatment strategies

AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis

Play Episode Listen Later Nov 17, 2025 52:08

This activity was supported by an educational grant from Vor Bio. Please go to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://academiccme.com/MG-AANEM-25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 4, 2026.

management conference patients credit emerging new data inhibitors generalized myasthenia gravis baff

ESC 2025: Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering

Play Episode Listen Later Nov 17, 2025 30:24

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://academiccme.com/front-matter/esc25-2/⁠⁠⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through October 20, 2026.

data conference credit relevant lowering merck pertaining ldl c

Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Play Episode Listen Later Oct 28, 2025 73:27

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠ academiccme.com/ccrwestsle⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

treat credit severe targeted bristol myers squibb refractory car t cell therapy systemic lupus erythematosus cd19

Clinical Update on Non-Cystic Fibrosis Bronchiectasis: Strategies to Manage Exacerbations and Lung Function

Play Episode Listen Later Oct 28, 2025 25:58

This activity was supported by an educational grant from Insmed. Please go to ⁠ https://academiccme.com/epcncfbepod/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 7, 2026.

strategy manage credit clinical cystic fibrosis lung function

Conference Review and Analysis of Relevant Data Pertaining to LDL-C

Play Episode Listen Later Oct 28, 2025 30:24

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠⁠⁠⁠⁠⁠⁠⁠https://academiccme.com/front-matter/esc25-1/⁠⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 20, 2026.

data conference credit relevant merck pertaining ldl c

Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia

Play Episode Listen Later Aug 21, 2025 52:12

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠⁠⁠⁠⁠https://academiccme.com/front-matter/esc25-1/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 20, 2026.

care risk patients credit standards foundational merck dyslipidemia

Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis

Play Episode Listen Later Jul 31, 2025 25:09

This activity was supported by an educational grant from EMD Serono. Please go to ⁠⁠academiccme.com/McDonaldPod and complete the evaluation to receive your CE/CME Credit. Credit is available through October 23, 2025.

management patients mcdonald credit criteria multiple sclerosis emd serono

Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists

Play Episode Listen Later Jul 18, 2025 40:12

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠academiccme.com/HFPod and complete the evaluation to receive your CE/CME Credit. Credit is available through May 15, 2026.

credit implications specialists heart failure bristol myers squibb obstructive hypertrophic cardiomyopathy

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Play Episode Listen Later Jul 16, 2025 49:24

This activity was supported by an educational grant from Alnylam Pharmaceuticals. Please go to ⁠academiccme.com and complete the evaluation to receive your CE/CME Credit. Credit is available through June 25, 2026.

conference credit cardiomyopathy amyloidosis attr alnylam pharmaceuticals therapeutic advances transthyretin

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies

Play Episode Listen Later Mar 17, 2025 36:38

This activity was supported by an educational grant from Insmed. Please go to ⁠https://academiccme.com/front-matter/epcncfbe/ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

credit clinical trials therapies diagnostics cystic fibrosis newer pathophysiology

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

Play Episode Listen Later Mar 17, 2025 38:09

This activity was supported by an educational grant from Merck & Co., Inc.. Please go to ⁠https://academiccme.com/front-matter/epcpah/ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

patients credit emerging merck therapeutics signaling inhibitor improve outcomes

Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD

Play Episode Listen Later Dec 3, 2024 29:06

This activity was supported by an educational grant from Mylan Specialty L.P., a Viatris Company. Please go to ⁠academiccme.com/front-matter/copd-podcast/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 2, 2025.

strategy patients credit reduce clinical maintenance therapies copd newer

DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria

Play Episode Listen Later Nov 21, 2024 26:46

This activity was supported by an educational grant from Travere Therapeutics. Please go to ⁠https://academiccme.com/CKDCE3/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through November 21, 2025.

credit reduce blocking renal receptors proteinuria travere therapeutics

PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy

Play Episode Listen Later Nov 5, 2024 32:11

This activity was supported by an educational grant from Ipsen. Please go to ⁠academiccme.com/PBCCME⁠⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.

practice therapy treatments credit symptoms optimizing second line ipsen

Clinical Trial Data Review for PBC Therapeutics

Play Episode Listen Later Oct 17, 2024 31:09

This activity was supported by an educational grant from Ipsen. Please go to ⁠academiccme.com/PBCCME⁠⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.

data credit clinical trials therapeutics ipsen

PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease

Play Episode Listen Later Oct 16, 2024 37:57

This activity was supported by an educational grant from Ipsen. Please go to academiccme.com/PBCCME⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.

science strategy disease treatments credit timing burden optimal diagnostic ipsen

A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

Play Episode Listen Later Aug 6, 2024 71:30

This activity was supported by an educational grant from argenx US Inc. Please go to ⁠⁠academiccme.com/MGInfusionsCE⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 5, 2025.

credit administration scientific monitoring practical guide blockers infusion generalized myasthenia gravis

IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment

Play Episode Listen Later Jun 19, 2024 24:22

This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/CKDCE1/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.

treatments credit epidemiology bristol myers squibb pathophysiology nephropathy clinical presentation

VTE and Anticoagulation - Guideline Updates for 2024

Play Episode Listen Later Apr 25, 2024 28:29

This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE4/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.

credit guidelines bristol myers squibb anticoagulation

Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE

Play Episode Listen Later Mar 26, 2024 29:35

This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE3/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.

care patients credit promote continuity adherence bristol myers squibb patient education shared decision making doacs

Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE

Play Episode Listen Later Feb 15, 2024 31:45

This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE/ and complete the evaluation to receive your CE/CME Credit.

data real world clinical trials therapeutics anticoagulation doac

Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE

Play Episode Listen Later Jan 10, 2024 31:45

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to https://academiccme.com/VTECE/ and complete the evaluation to receive your CE/CME Credit.

data real world clinical trials therapeutics anticoagulation doac

Part 1: Advances in Patient-Actuated Treatment for PSVT

Play Episode Listen Later Aug 16, 2023 28:10

This activity was supported by an educational grant from Milestone Pharmaceuticals. Please go to academiccme.com/PSVTpodcast/ and complete the evaluation to receive your CE/CME Credit.

patients treatments advances psvt

Part 2: Advances in Patient-Actuated Treatment for PSVT

Play Episode Listen Later Aug 16, 2023 35:06

This activity was supported by an educational grant from Milestone Pharmaceuticals. Please go to academiccme.com/PSVTpodcast/ and complete the evaluation to receive your CE/CME Credit.

patients treatments advances psvt

Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer

Play Episode Listen Later Jan 9, 2023 61:02

Please go to academiccme.com/ovariancancer/ and complete the evaluation to receive your CE/CME Credit.

patients treatments maintenance ovarian cancer inhibitors parp improve outcomes polymerase ribose

Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies

Play Episode Listen Later Jan 3, 2023 31:19

Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.

patients treat studies challenging case study multidisciplinary comorbidities interprofessional hyperkalemia

Hyperkalemia 3: Clinical Trial Update for Newer Therapeutic Options to Treat Hyperkalemia

Play Episode Listen Later Jan 3, 2023 24:42

Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.

treat options therapeutic clinical trials newer hyperkalemia

Hyperkalemia Part 2: Understand the limitations and impact of plant-based diets and potassium restricted diets on the incidence and severity of hyperkalemia

Play Episode Listen Later Jan 3, 2023 26:43

Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.

limitations restricted severity potassium incidence plant based diets hyperkalemia

Hyperkalemia Part 1: Review the Science of Recurrent Hyperkalemia, Including Relationships Between Dietary Potassium Intake, Serum Potassium, and Patient Morbidities

Play Episode Listen Later Jan 3, 2023 26:49

Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.

relationships science patients dietary intake serum recurrent potassium hyperkalemia

Avances en el tratamiento de la ERC con inhibidores de SGLT2 en pacientes con y sin diabetes: el ensayo EMPA-KIDNEY

Play Episode Listen Later Dec 27, 2022 31:10

Vaya a https://academiccme.com/empa-kidney-es-podcast/ y complete la evaluación para recibir su crédito CE/CME.

diabetes kidney vaya pacientes tratamiento avances ensayo sglt2 empa

Kombinationstherapie der chronischen Nierenerkrankung: Die EMPA-Kidney Studie

Play Episode Listen Later Dec 22, 2022 28:38

Bitte gehen Sie zu https://academiccme.com/empa-kidney-de-podcast/ und füllen Sie die Bewertung aus, um Ihren CE/CME Credit zu erhalten.

bitte studie kidney empa nierenerkrankung

EMPA-Kidney: la révolution de la néphroprotection par les inhibiteurs SGLT-2 est là

Play Episode Listen Later Dec 21, 2022 53:28

Veuillez vous rendre sur https://academiccme.com/empa-kidney-fr-podcast/ et compléter l'évaluation pour recevoir votre crédit CE/CME.

kidney veuillez empa sglt

Advances in Slowing the Progression of CKD with SGLT2 Inhibitors

Play Episode Listen Later Dec 15, 2022 20:05

Please go to https://academiccme.com/empa-kidney-podcast/ and complete the evaluation to receive your CE/CME Credit.

progression advances slowing inhibitors sglt2